Evidence map›Paper›PMID 31624460›Full record

ArticleBiochemia medica2019

Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma.

Benjamin Lopez, Nicolas Bertier, Emmanuel Ledoult, Romane Joudinaud, Mehdi Maanaoui, Victoria Majerus, Emmanuelle Moitrot, Anne-Sophie Deleplancque, Stéphanie Rogeau, David Launay and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Biochemia medica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Benjamin LopezDepartment of Immunology, Lille University Hospital, Lille, France.
Nicolas BertierDepartment of Immunology, Lille University Hospital, Lille, France.
Emmanuel LedoultDepartment of Immunology, Lille University Hospital, Lille, France.
Romane JoudinaudDepartment of Immunology, Lille University Hospital, Lille, France.
Mehdi MaanaouiDepartment of Immunology, Lille University Hospital, Lille, France.
Victoria MajerusDepartment of Immunology, Lille University Hospital, Lille, France.
Emmanuelle MoitrotDepartment of Immunology, Lille University Hospital, Lille, France.
Anne-Sophie DeleplancqueDepartment of Immunology, Lille University Hospital, Lille, France.
Stéphanie RogeauDepartment of Immunology, Lille University Hospital, Lille, France.
David LaunayLille Inflammation Research International Center, University of Lille, Lille, France.
Guillaume LefèvreDepartment of Immunology, Lille University Hospital, Lille, France.
Myriam LabaletteDepartment of Immunology, Lille University Hospital, Lille, France.
Sylvain DubucquoiDepartment of Immunology, Lille University Hospital, Lille, France.
Université de Lille · FRLille Inflammation Research International Center · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionReference intervals (RIs) for complement assays in EDTA plasma samples have not previously been published. The objectives of the present study were to validate and/or determine RIs for classical pathway (CP50) activity and C3c, C4 and C1 inhibitor protein (C1INH) assays and to assess the need for age-specific RIs in EDTA plasma. MATERIALS AND

methodsWe retrospectively evaluated a cohort of 387 patients attending our university hospital and known to be free of complement-modifying diseases. The need for age partitioning was assessed and RIs were calculated according to the CLSI protocol.

resultsNo need for age partitioning was evidenced for CP50 activity, C3c and C4 concentrations and RIs (90% CI) were calculated from the pooled data: 35.4 (33.1-37.2) to 76.3 (73.7-83.6) U/mL for CP50 activity, 0.80 (0.75-0.87) to 1.64 (1.59-1.72) g/L for C3c, and 0.12 (0.10-0.14) to 0.38 (0.36-0.40) g/L for C4. Our results highlight a positive association between age and C1INH concentrations. We derived 3 age partitions (6 months to 30 years, 30-50 and > 50 years) and the related RIs: 0.20 (0.18-0.21) to 0.38 (0.36-0.40) g/L, 0.22 (0.20-0.24) to 0.39 (0.36-0.41) g/L and 0.25 (0.22-0.27) to 0.41 (0.40-0.43) g/L, respectively).

conclusionsThe newly determined RIs for CP50 activity were higher than those provided by the manufacturer for EDTA plasma samples, whereas those for C3c and C4 RIs were similar to the values provided for serum samples. The C1INH concentration and activity were found to be associated with age and age-specific RIs are mandatory for this analyte.

Indexed as

AdolescentAdultAgedAged, 80 and overComplement C1 Inhibitor ProteinComplement C3cComplement C4FemaleHumansMaleMiddle AgedReference ValuesRetrospective StudiesYoung AdultComplement C1 Inhibitor ProteinComplement C3cComplement C4classical complement pathwaycomplement C1 inhibitor proteincomplement C3ccomplement C4reference values

Identifiers

PMID31624460
PMCPMC6784422
OpenAlexW2979512941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.